3Bideni AK, Griffin LD. Renal conseqnences of hyperten- sion for normaland diseaseskidneyCurr. Op in Nephrol Hypertens ,2002,11:73.
4Bakris GL. Progression of diabetic nephropat hy : a focus on arte2rial pressure level and met hods of reduction[ J]. Diabetes ResClin Pract , 1998 ,39 :S35242.
5Whitworth JA, World Health Organization, International Society of Hyper2tensionWriting Group. 2003 World Health Organization (WHO) Interna2tional Society of Hypertension ( ISH ) Statememt on management of hyper2tension. J Hypertens ,2003,21 : 198321992.
6Maschio G, Alberti D, J anin G, et al. Effect of angiotensin2corr2verting2enzyme inhibitor benazepril on t he progression of chronicrenal insufficiency [ J ]. N Eng J Med, 1996,334 : 9392947.
7HOU FF Zhang X, Zhang GH, et al. Efficacy and safety ofbenazepril for advanced chronic renal insufficiency [ J ]. N Engl JMed,2006,354 : 1312140.
7[1]Ruliope LM.The kidney as a sensor of cardiovascular risk in essential hypertension[J].J Am Soc Nephrol,2002,13:S165-168.
8[2]USRDS 2001 Annual Data Report.Atlas of end-stage renal disease in the United States,national institutes of health,national institute of diabetes and digestive and kidney diseases[M].Bethesda,MD,US Renal Data System,2001.
9[3]The multiple risk factor intervention trial research group.Mortality after 16 years for participants randomized to the multiple risk factor intervention trial[J].Circulation,1996,94:946-951.
10[5]Liao YH,Wei YM,Wang M,et al.Autoantibodies against AT-1-Receptor and α1-Adrenergic receptor in patients with hypertension[J].Hypertens Res,2002,25:641-646.
